Effect of CPAP treatment on blood pressure levels in resistant hypertension. A multicenter randomized study from the Spanish sleep network (NCT00616265)

被引：0

作者：

Angel Martinez-Garcia, Miguel ^{[1
]}

Capote, Francisco ^{[2
]}

Campos-Rodriguez, Francisco ^{[3
]}

Lloberes, Patricia ^{[4
]}

Diaz de Atauri, Maria Josefa ^{[5
]}

Somoza, Maria ^{[6
]}

Masa, Fernando ^{[7
]}

Gonzalez, Monica ^{[8
]}

Sacristan, Lirios ^{[9
]}

Barbe, Ferran ^{[10
]}

Duran-Cantolla, Joaquin ^{[11
]}

Maria Montserrat, Jose ^{[12
]}

机构：

[1] La Fe Univ Hosp, Serv Pneumol, Valencia, Spain

[2] Virgen del Rocio Univ Hosp, Serv Pneumol, Seville, Spain

[3] Valme Univ Hosp, Serv Pneumol, Seville, Spain

[4] Vall Hebron Univ Hosp, Serv Pneumol, Barcelona, Spain

[5] 12 Octubre Univ Hosp, Serv Pneumol, Madrid, Spain

[6] Terrassa Hosp, Serv Pneumol, Terrassa, Spain

[7] San Pedro de Alcantara Univ Hosp, Serv Pneumol, Caceres, Spain

[8] Marques de Valdecilla Univ Hosp, Serv Pneumol, Santander, Spain

[9] Villajoiosa Hosp, Pneumol Unit, Alicante, Spain

[10] Arnau de Vilanova Univ Hosp, Serv Pneumol, Lleida, Spain

[11] Arava Univ Hosp, Serv Pneumol, Vitoria, Spain

[12] IDIBAPS Clin Univ Hosp, Serv Pneumol, Barcelona, Spain

来源：

EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷

关键词：

Circulation; Sleep studies; Sleep disorders;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

7141

引用

页数：2

共 50 条

[41] The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial)
Peters, Christian Daugaard
Mathiassen, Ole Norling
Vase, Henrik
Norgaard, Jesper Bech
Christensen, Kent Lodberg
Schroeder, Anne Pauline
Rickers, Hans Joachim von Hofe
Opstrup, Ulla Kampmann
Poulsen, Per Logstrup
Langfeldt, Sten
Andersen, Gratien
Hansen, Klavs Wuergler
Botker, Hans Erik
Engholm, Morten
Bertelsen, Jannik Buus
Pedersen, Erling Bjerregaard
Kaltoft, Anne
Buus, Niels Henrik
BLOOD PRESSURE, 2017, 26 (06) : 366 - 380
[42] Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension A Randomized, Double-Blind, Placebo-Controlled Study
Kereiakes, Dean J.
Maa, Jen-Fue
Shojaee, Ali
Dubiel, Robert
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (04) : 239 - 246
[43] Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET Study
Nolde, Janis M.
Atkins, Emily
Marschner, Simone
Hillis, Graham S.
Chalmers, John
Billot, Laurent
Nelson, Mark R.
Reid, Christopher M.
Hay, Peter
Burke, Michael
Jansen, Shirley
Usherwood, Tim
Rodgers, Anthony
Chow, Clara K.
Schlaich, Markus P.
CIRCULATION, 2023, 148 (04) : 375 - 377
[44] Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Multicenter Study
Kario, Kazuomi
Rakugi, Hiromi
Yarimizu, Daisuke
Morita, Yohei
Eguchi, Shunsuke
Iekushi, Kazuma
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (08):
[45] A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]
Cornel Pater
Deepak Bhatnagar
Jean-Pascal Berrou
Joachim Luszick
Katrin Beckmann
Current Controlled Trials in Cardiovascular Medicine, 2004, 5
[46] A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]
Pater, C
Bhatnagar, D
Berrou, JP
Luszick, J
Beckmann, K
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2004, 5 (1):
[47] Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)
Chung, Woo-Baek
Ihm, Sang-Hyun
Jang, Sung-Won
Her, Sung-Ho
Park, Chul Soo
Lee, Jong-Min
Chang, Kiyuk
Jeon, Doo-Soo
Yoo, Ki-Dong
Seung, Ki-Bae
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 347 - 360
[48] Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study)
Hashimoto-Kameda, Reina
Cho, Kyu Yong
Nomoto, Hiroshi
Nakamura, Akinobu
Omori, Kazuno
Nagai, So
Edagawa, Sachiko
Kawata, Shinichiro
Takeuchi, Jun
Kameda, Hiraku
Kurihara, Yoshio
Aoki, Shin
Atsumi, Tatsuya
Miyoshi, Hideaki
DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 180
[49] Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension Results From the Randomized, Placebo-Controlled SACRA Study
Kario, Kazuomi
Okada, Kenta
Kato, Mitsutoshi
Nishizawa, Masafumi
Yoshida, Tetsuro
Asano, Tsuguyoshi
Uchiyama, Kazuaki
Niijima, Yawara
Katsuya, Tomohiro
Urata, Hidenori
Osuga, Jun-ichi
Fujiwara, Takeshi
Yamazaki, Shoji
Tomitani, Naoko
Kanegae, Hiroshi
CIRCULATION, 2019, 139 (18) : 2089 - 2097
[50] Twenty-four hour blood pressure-lowering effect of a sodium-glucose cotransporter-2 inhibitor in patients with diabetes and uncontrolled nocturnal hypertension - results from the randomized, placebo-controlled SACRA study
Koppelstaetter, Christian
JOURNAL FUR HYPERTONIE, 2019, 23 (02): : 57 - 58

← 1 2 3 4 5 →